Results 141 to 150 of about 10,157,624 (223)

Primary Sinonasal Non-Hodgkin's Lymphoma Masquerading as Chronic Rhinosinusitis: An Issue of Routine Histopathological Examination

, 2008
Primary non-Hodgkin's lymphoma (NHL) of the sinonasal tract is uncommon. Morphologically and radiographically, sinonasal lymphomas are difficult to distinguish from other malignant neoplasms or nonneoplastic processes.
吳傳頌;詹光漢;洪元宗;孫家棟;劉嘉銘, WU, CHUAN-SONG;CHAN, KUANG-HAN;HONG, YONG-TSUNG;SHUN, CHIA-TUNG;LIU, CHIA-MING   +1 more
core  

How Hot Is Too Hot? Fever Thresholds for Initiating Antibiotics in Children With Haematological Malignancies

Acta Paediatrica, EarlyView.
C. S. V. Henriksen, U. Nygaard, G. Petersen, J. Brok, L. L. Hjalgrim, N. V. Vissing, M. B. Mønster   +6 more
wiley   +1 more source

SENIOR‐IPI: An easily applicable prognostic index for first‐line large B‐cell lymphomas patients >80 years treated with curative intent

British Journal of Haematology, EarlyView.
Summary Using LYmphoma Study Association clinical trials combining 438 first‐line large B‐cell lymphomas (LBCL) patients >80 years old, we defined SENIOR‐IPI, an easily applicable prognostic index for this elderly population treated with an anti‐CD20‐miniCHOP (cyclophosphamide, doxorubicin, vincristine and prednisone)‐based regimen.
Sydney Dubois, Fanny Cherblanc, Aurelien Belot, Lucie Oberic, Hervé Ghesquières, Corinne Haioun, Hervé Tilly, Jean‐Philippe Jais, Fabrice Jardin   +8 more
wiley   +1 more source

Analysis of anxiety and depression and influencing factors in non-Hodgkin's lymphoma of the nasal cavity and paranasal sinus. [PDF]

World J Psychiatry
Gao XD, Zhang J, Li A, Ding Y, Zhao B, Li L.   +5 more
europepmc   +1 more source

Efficacy and safety of high doses of eltrombopag for treating adult immune thrombocytopenia: Results from a multicentre retrospective cohort study

British Journal of Haematology, EarlyView.
Salomé Dahan, Stéphanie Guillet, Olivier Fain, Delphine Gobert, Stéphane Cheze, Florent Broca, Bertrand Godeau, Marc Michel   +7 more
wiley   +1 more source

Development and validation of a model for stratifying haematological malignancy risk in primary care using basic blood tests

British Journal of Haematology, EarlyView.
Summary Haematological malignancies are rare in primary care and are hard to predict. Existing prediction models often require a specific working diagnosis and are based on extensive clinical information, access to which may be limited at initial work‐up in primary care.
Mathilde Egelund Christensen, Michael Charles Sachs, William Grant Dunn, Gustav Jonzon, Margit Kriegbaum, Bent Struer Lind, Jan Samuelsson, Kirsten Groenbaek, George Vassiliou, Christen Lykkegaard Andersen   +9 more
wiley   +1 more source

Acute Cauda Equina Syndrome Following Transpedicular Biopsy of a Lumbar Vertebral Lesion: A Case Report of Spinal Non-Hodgkin's Lymphoma. [PDF]

J Orthop Case Rep
Gohil KR, Gawhale SK, Barman J, Selwal N, Agarwal AA, Kumar P.   +5 more
europepmc   +1 more source

SAKK 35/14 randomized trial of rituximab with or without ibrutinib for patients with untreated follicular lymphoma

British Journal of Haematology, EarlyView.
Summary The randomized phase II SAKK 35/14 trial, conducted by the Swiss Group for Clinical Cancer Research (SAKK) and the Nordic Lymphoma Group (NLG), compared efficacy and safety of rituximab (375 mg/m2 intravenously for 4 weeks followed by maintenance every 2 months for 24 months) plus placebo (arm A) versus the same schedule of rituximab plus ...
Maria Cristina Pirosa, Marianne Brodtkorb, Sämi Schär, Björn E. Wahlin, Micaela Hernberg, Michael Pedersen, Anastasios Stathis, Thilo Zander, Urban Novak, Thorsten Zenz, Natalie Fischer, Fatime Krasniqi, Felicitas Hitz, Ann‐Sofie Johansson, David Löfgren, Peter Albert Meyer, Anne Turid Bjørnevik, Giulio Sartori, Stefanie Hayoz, Andrea Fuhrer, Luzia Steiner, Francesco Bertoni, Luca Ceriani, Stefan Dirnhofer, Emanuele Zucca, Bjørn Østenstad   +25 more
wiley   +1 more source

Pharmacologic activity, safety, and preliminary efficacy of GEN3009, a CD37-targeting DuoHexaBody, in relapsed or refractory B-cell non-Hodgkin's lymphoma. [PDF]

J Immunother Cancer
Awan FT, Gamse JT, Overdijk MB, Breij ECW, Jure-Kunkel M, Sanghavi K, Brady LK, Guan M, Verbrugge I, Chen J, Gong N, Gillespie M, Tees M, Gallogly M, Hutchings M, Christensen JH, Sureda A, Cordoba R, Ahmed S, Woei-A-Jin FJSH, Abrisqueta P, Giné E, Roost Clausen M, Bhat SA, Gopal AK, Chamuleau MED.   +25 more
europepmc   +1 more source

Histopathological Evaluation of Angiogenic Markers in Non-Hodgkin's Lymphoma. [PDF]

J Lab Physicians, 2023
Singh P, Tahlan A, Mohan H, Singh R.
europepmc   +1 more source